We are live on ! Find out more
SCM

Stonebridge Capital Management Portfolio holdings

AUM $220M
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$279M
AUM Growth
+$6.05M
Cap. Flow
+$2.98B
Cap. Flow %
1,065.92%
Top 10 Hldgs %
35.94%
Holding
143
New
7
Increased
35
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.97B
2
AAPL icon
Apple
AAPL
+$8.1M
3
SBUX icon
Starbucks
SBUX
+$5.41M
4
IBM icon
IBM
IBM
+$2.49M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 18%
3 Industrials 11.8%
4 Energy 11.33%
5 Consumer Staples 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
51
Becton Dickinson
BDX
$46.4B
$1.22M 0.44%
5,151
ABT icon
52
Abbott
ABT
$188B
$1.16M 0.41%
18,826
AGN
53
DELISTED
Allergan plc
AGN
$1.14M 0.41%
6,596
+850
+15% +$136K
ABBV icon
54
AbbVie
ABBV
$465B
$1.1M 0.39%
11,632
-500
-4% -$48.8K
MCD icon
55
McDonald's
MCD
$193B
$1.08M 0.39%
6,840
+240
+4% +$38.9K
KMB icon
56
Kimberly-Clark
KMB
$37.6B
$1.04M 0.37%
9,700
GPC icon
57
Genuine Parts
GPC
$17.9B
$990K 0.35%
10,833
-4,298
-28% -$392K
AMAT icon
58
Applied Materials
AMAT
$347B
$934K 0.33%
20,550
RDS.B
59
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$931K 0.33%
12,894
REGN icon
60
Regeneron Pharmaceuticals
REGN
$72.9B
$902K 0.32%
2,499
+166
+7% +$51.9K
SNY icon
61
Sanofi
SNY
$107B
$896K 0.32%
21,306
+7,919
+59% +$312K
VAR
62
DELISTED
Varian Medical Systems, Inc.
VAR
$889K 0.32%
7,690
-50
-0.6% -$5.98K
GSK icon
63
GSK
GSK
$107B
$885K 0.32%
17,383
+357
+2% +$18K
BIIB icon
64
Biogen
BIIB
$30.9B
$825K 0.3%
2,761
+100
+4% +$28.1K
UN
65
DELISTED
Unilever NV New York Registry Shares
UN
$809K 0.29%
14,400
BCE icon
66
BCE
BCE
$20.8B
$719K 0.26%
17,590
+3,090
+21% +$130K
NSC icon
67
Norfolk Southern
NSC
$75.4B
$680K 0.24%
4,445
DD icon
68
DuPont de Nemours
DD
$18.6B
$660K 0.24%
3,943
LLL
69
DELISTED
L3 Technologies, Inc.
LLL
$648K 0.23%
3,348
VRTX icon
70
Vertex Pharmaceuticals
VRTX
$123B
$630K 0.23%
3,722
CAG icon
71
Conagra Brands
CAG
$7.42B
$589K 0.21%
16,400
-500
-3% -$18.6K
NGG icon
72
National Grid
NGG
$79.3B
$579K 0.21%
11,339
-23
-0.2% -$1.16K
SJR
73
DELISTED
Shaw Communications Inc.
SJR
$568K 0.2%
27,925
-12,275
-31% -$251K
WFC icon
74
Wells Fargo
WFC
$254B
$536K 0.19%
9,701
AMGN icon
75
Amgen
AMGN
$209B
$533K 0.19%
2,847
-46,295
-94% -$8.19M

Similar funds

Stonebridge Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Stonebridge Capital Management held 143 positions worth $279M, up 2.2% from $273M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stonebridge Capital Management deployed $2.98B of net new capital in Q2 2018, opening 7 new positions and adding to 35 existing holdings. Its largest new stake was Starbucks: 95,337 shares worth $4.63M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $8.19M trimmed.

  • Stonebridge Capital Management's largest Q2 2018 buy was Starbucks: 95,337 shares worth $4.63M.
  • Stonebridge Capital Management added most to Berkshire Hathaway Class A in Q2 2018, an estimated $2.97B increase.
  • Stonebridge Capital Management's biggest Q2 2018 reduction was Amgen, cutting an estimated $8.19M.
  • Stonebridge Capital Management fully exited Monsanto Co in Q2 2018, selling an estimated $963K.
  • Stonebridge Capital Management's ten largest holdings make up 36% of its $279M portfolio in Q2 2018.
  • Stonebridge Capital Management opened 7 new positions and closed 7 in Q2 2018.
  • Stonebridge Capital Management's portfolio value rose 2.2% quarter-over-quarter to $279M.

Based on Stonebridge Capital Management's 13F filing for Q2 2018, filed 6 Jul 2018.